Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Second DHPC on Ketoprofen - Important Safety Information from A.Menarini Pharmaceuticals as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
13/12/2010
Problem Or Issue:
Important safety information communication from A.Menarini Pharmaceuticals on risk minimization measures for ketoprofen-containing topical formulations.
Important Safety Information - Ketoprofen
Note that this is the second DHPC from A.Menarini Pharmaceuticals on this issue as part of a commitment to continued risk minimization as agreed with the EMA; the
Second DHPC on Ketoprofen - Important Safety Information from A.Menarini Pharmaceuticals as approved by the Irish Medicines Board
was issued in August 2010.
« Back
Date Printed: 16/05/2024